The compound THCA derived from cannabis could be used one day to treat Huntington’s Disease and other neurodegenerative and neuroinflammatory diseases, according to a study published recently in the British Journal of Pharmacology.

Researchers found that THCA, an acidic precursor of THC, reduced inflammation and served as a neuroprotectant when they analyzed cannabis compounds in animals. In the study, the compound improved motor function and prevented brain degeneration.

Click here to read the entire article

 

Article by: Ryan Basen on Leafly